BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 18568530)

  • 1. Modern imaging of multiple myeloma.
    Seppanen M
    Acta Radiol; 2008 Jun; 49(5):487-8. PubMed ID: 18568530
    [No Abstract]   [Full Text] [Related]  

  • 2. Imaging in multiple myeloma.
    Delorme S; Baur-Melnyk A
    Eur J Radiol; 2009 Jun; 70(3):401-8. PubMed ID: 19272726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myeloma update.
    Mulligan ME
    Semin Musculoskelet Radiol; 2007 Sep; 11(3):231-9. PubMed ID: 18260033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. F-18 FDG PET/CT staging of multiple myeloma with diffuse osseous and extramedullary lesions.
    Wiesenthal AA; Nguyen BD
    Clin Nucl Med; 2007 Oct; 32(10):797-801. PubMed ID: 17885362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Imaging patients with myeloma.
    Winterbottom AP; Shaw AS
    Clin Radiol; 2009 Jan; 64(1):1-11. PubMed ID: 19070692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of magnetic resonance imaging-fluorodeoxyglucose positron emission tomography fusion with pathological staging in rectal cancer (Br J Surg 2010; 97: 266-268).
    Talapatra K; Mallick S
    Br J Surg; 2010 Jul; 97(7):1151; author reply 1151. PubMed ID: 20632294
    [No Abstract]   [Full Text] [Related]  

  • 7. Marginal zone lymphoma involving subcutaneous fat: appearance by FDG-PET/CT, MRI, and contrast-enhanced CT imaging.
    Chong EA; Torigian DA; Mato AR; Downs LH; Schuster SJ
    Clin Nucl Med; 2008 Oct; 33(10):692-3. PubMed ID: 18806570
    [No Abstract]   [Full Text] [Related]  

  • 8. Fluorine-18-deoxyglucose-positron emission tomography imaging with magnetic resonance and computed tomographic correlation in the evaluation of bone and soft-tissue sarcomas: a pictorial essay.
    Tewfik JN; Greene GS
    Curr Probl Diagn Radiol; 2008; 37(4):178-88. PubMed ID: 18502325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of anatomic and functional staging in myeloma: description of Durie/Salmon plus staging system.
    Durie BG
    Eur J Cancer; 2006 Jul; 42(11):1539-43. PubMed ID: 16777405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hematopoietic tumors and metastases involving bone.
    Kim SH; Smith SE; Mulligan ME
    Radiol Clin North Am; 2011 Nov; 49(6):1163-83, vi. PubMed ID: 22024293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abdominal manifestations of extraosseous myeloma: cross-sectional imaging spectrum.
    Philips S; Menias C; Vikram R; Sunnapwar A; Prasad SR
    J Comput Assist Tomogr; 2012; 36(2):207-12. PubMed ID: 22446361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Update on diagnostic imaging for melanoma.
    Grasee EA; Wagner JD
    Facial Plast Surg Clin North Am; 2003 Feb; 11(1):49-60. PubMed ID: 15062287
    [No Abstract]   [Full Text] [Related]  

  • 13. Retroperitoneal plasmacytoma.
    Safar B; Thupili C; Gandhi N
    J Urol; 2013 Jul; 190(1):280-1. PubMed ID: 23602634
    [No Abstract]   [Full Text] [Related]  

  • 14. [Diagnosis and follow-up with 18F-fluorodeoxiglucose positron emission tomography/computed tomography of extraosseous myeloma].
    Garcia JR; Canales M; Ponce A; Buxeda M; Moragas M; Soler M
    Rev Esp Med Nucl Imagen Mol; 2014; 33(2):115-7. PubMed ID: 23867637
    [No Abstract]   [Full Text] [Related]  

  • 15. Use of 99mTc-sestamibi scintigraphy in multiple myeloma.
    Pace L; Salvatore M; Del Vecchio S
    J Nucl Med; 2006 Mar; 47(3):555. PubMed ID: 16513630
    [No Abstract]   [Full Text] [Related]  

  • 16. Positron emission tomography/computed tomography for staging and restaging of head and neck cancer: comparison with positron emission tomography read together with contrast-enhanced computed tomography.
    Goerres GW; Schuknecht B; Schmid DT; Stoeckli SJ; Hany TF
    Clin Imaging; 2008; 32(6):431-7. PubMed ID: 19006770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple myeloma.
    Peller PJ
    PET Clin; 2015 Apr; 10(2):227-41. PubMed ID: 25829088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. (18)F-Fluorodeoxyglucose avid liver lesion in a patient with multiple myeloma.
    Matsue K; Odawara J; Kimura S; Yamakura M; Takeuchi M
    Eur J Haematol; 2009 Aug; 83(2):163-4. PubMed ID: 19226413
    [No Abstract]   [Full Text] [Related]  

  • 19. Positron emission tomography with computed tomography-based diagnosis of massive extramedullary progression in a patient with high-risk multiple myeloma.
    Zamagni E; Nanni C; Tacchetti P; Pantani L; Marzocchi G; Zannetti B; Terragna C; Mancuso K; Rocchi S; Pezzi A; Testoni N; Fanti S; Cavo M
    Clin Lymphoma Myeloma Leuk; 2014 Jun; 14(3):e101-4. PubMed ID: 24508412
    [No Abstract]   [Full Text] [Related]  

  • 20. Multiple myeloma presenting with [18F]fluorodeoxyglucose avid liver lesions diagnosed on positron emission tomography scan.
    Ghesani M; Goel S; Cohen S; Maslin P; Meka M; Chang A
    J Clin Oncol; 2007 Nov; 25(33):5319-20. PubMed ID: 18024877
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.